Table 2. Risk factors for sarcopenia in patients with IBD.
| Factors | Univariate logistic regression | Multivariate logistic regression | |||||
|---|---|---|---|---|---|---|---|
| β | OR | P value | β | OR | P value | ||
| Sex | 0.979 | 2.662 | 0.022* | – | – | – | |
| BMI (kg/m2) | −0.498 | 0.607 | <0.001* | −0.766 | 0.449 | 0.018* | |
| Alcohol consumption history | 2.383 | 10.833 | <0.001* | – | – | – | |
| Gastrointestinal surgery history | 0.742 | 2.100 | 0.090 | – | – | – | |
| Parenteral manifestations | 2.582 | 13.222 | <0.001* | – | – | – | |
| IBD-related complications | 3.899 | 49.333 | <0.001* | – | – | – | |
| Alb (g/L) | −0.491 | 0.613 | <0.001* | −0.482 | 0.608 | 0.004* | |
| CRP (mg/L) | 0.111 | 1.117 | 0.001* | – | – | – | |
| ESR (mm/60 min) | 0.094 | 1.099 | <0.001* | – | – | – | |
| Hb (g/L) | −0.026 | 0.974 | 0.004* | – | – | – | |
*, P<0.05 was considered statistically significant. OR, odds ratio; β, regression coefficient; BMI, body mass index; IBD, inflammatory bowel disease; Alb, albumin; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; Hb, hemoglobin.